CThe UT&Tag Assay Kit for Illumina is a library construction kit developed for the Illumina high-throughput sequencing platform for studying protein-DNA interactions. CUT&Tag (Cleavage Under Targets and Tagmentation) is a novel technique for studying protein-DNA interactions: After chromatin proteins are in situ bound by specific antibodies, targeted binding and precise cleavage using Protein A-Tn5 fusion protein can effectively generate fragment libraries with high resolution and extremely low background.
Compared with the traditional ChIP-Seq, the CUT&Tag method provided by this kit has the advantages of low cell usage, simple operation, short cycle and high signal-to-noise ratio. It is suitable for detecting specific transcription factor binding sites or the occurrence sites of specific histone modifications, etc., and can be applied in research fields such as epigenetics, early embryonic development, stem cells, and tumors.

1. Low initial sample size: Even as low as 100 cells can yield highly specific and high signal-to-noise ratio data.
2. pA-Tn5 evolution: A rationally designed mutant enzyme with extremely high transpostion efficiency, enhancing resolution at low cell volumes.
3. Optimization of extraction module: High-quality extraction magnetic beads, efficient recovery of 200bp small fragments, compatible with accurate fragment sorting processes.
4. Buffer system optimization: Promote efficient and highly specific binding of antibodies and transposases, and reduce background noise.
1.Application scenarios
Identification of transcription factor binding sites.
② Analysis of histone modifications.
③ Research on chromatin openness and construction of gene regulatory networks.
④ Single cells and CUT&Tag
⑤ Epigenetic regulation of organoids
2. Application type
① Basic research: Chromatin dynamics, transcriptional regulation, epigenetic mechanisms.
② Disease research: Cancer heterogeneity, screening for markers of neurodegenerative diseases.
③ Drug development: Verification of the mechanism of action of targeted epigenetic drugs.
3. Main application fields
① Academic research (70%) : Universities, research institutions.
② Pharmaceutical enterprises (25%) : Discovery of tumor drug targets.
③ Clinical diagnosis (5%) : Early exploration stage
0756-8699969
Address: No. 88, Shuian 1st Road, Xiangzhou District, Zhuhai City, Guangdong Province
Email: marketing@biori.com
Wechat official account |
Product consultation |
Video Account |